全部| 求助中| 待确认 按时间排序|按积分排序

Plozasiran and Apolipoprotein C-III Inhibition

用户6Y1jG6KofHy8 17小时前 10 已关闭

NEJM at ESC — Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk

用户6Y1jG6KofHy8 17小时前 10 已关闭

Olezarsen and Plozasiran in Dyslipidemia Management: A Narrative Review of Clinical Trials

用户6Y1jG6KofHy8 17小时前 10 待确认

A Comprehensive Investigation of Dog Cytochrome P450 3A (CYP3A) Reveals a Functional Role of Newly Identified CYP3A98 in Small Intestine

用户gJMFtDW4laqk 18小时前 10 已完结

Improved synthesis of bioactive L-penicillamine via an economical and environment-friendly route

用户QdfL33bvcLpU 18小时前 10 已完结

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

用户mKQO0T3T2ANY 18小时前 10 待确认

Interpretation of blood clotting studies and values (PT, PTT, aPTT, INR, anti-factor Xa, D-dimer)

用户mKQO0T3T2ANY 18小时前 10 待确认

Quantitative prediction of CYP3A‐mediated drug–drug interactions by correctly estimating fraction metabolized using human liver chimeric mice

用户oHMOpCK_KaMQ 18小时前 10 待确认

Human hepatocytes and cytochrome P450‐selective inhibitors predict variability in human drug exposure more accurately than human recombinant P450s

用户oHMOpCK_KaMQ 19小时前 10 已完结

Fixed-dose enoxaparin provides efficient DVT prophylaxis in mixed ICU patients despite low anti-Xa levels: A prospective observational cohort study

用户mKQO0T3T2ANY 19小时前 10 待确认
首页 上页 1 2 3 4 5 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com